HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression of RNA-binding protein HuR in non-small cell lung cancer correlates with vascular endothelial growth factor-C expression and lymph node metastasis.

Abstract
The expression levels of the RNA-binding protein Hu antigen (HuR) and vascular endothelial growth factor-C (VEGF-C) were examined immunohistochemically in 81 non-small cell lung cancers (NSCLC) and 15 benign human lung tissues. HuR showed a nuclear overexpression in 82.7% (67/81) of NSCLC specimens. Cytoplasmic immunoreactivity for HuR was observed in 45.7% (37/81) of NSCLC, while only nuclear expression of HuR was observed in 13.3% (2/15) of benign lung tissues. The expression of VEGF-C was present in a subgroup of 70.4% (57/81) of tumor cases. In the human NSCLC samples, cytoplasmic but not nuclear HuR expression was significantly associated with increased levels of VEGF-C and with clinicopathological variables, including high tumor grade, poor differentiation and lymph node metastasis. In vitro, HuR showed a predominantly nuclear staining in Lewis lung cancer cells, as seen by confocal microscopy. When lung cancer cells were treated with siRNA targeted against HuR, expression levels of the HuR and VEGF-C proteins were significantly reduced, as seen by Western blotting. Our findings indicate that there is a dysregulation of the cellular distribution of the mRNA stability factor HuR in a subset of NSCLC. Examination of cytoplasmic HuR in NSCLC tissues will allow for valuable prognostic diagnosis of lymph node metastasis, as HuR might be an important mediator regulating the expression of VEGF-C.
AuthorsJun Wang, Weipeng Zhao, Yan Guo, Bicheng Zhang, Qichao Xie, Debing Xiang, Jianfei Gao, Baocheng Wang, Zhengtang Chen
JournalOncology (Oncology) Vol. 76 Issue 6 Pg. 420-9 ( 2009) ISSN: 1423-0232 [Electronic] Switzerland
PMID19420963 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2009 S. Karger AG, Basel.
Chemical References
  • Antigens, Surface
  • ELAV Proteins
  • ELAV-Like Protein 1
  • ELAVL1 protein, human
  • RNA-Binding Proteins
  • Vascular Endothelial Growth Factor C
Topics
  • Adenocarcinoma (metabolism)
  • Aged
  • Antigens, Surface (biosynthesis)
  • Carcinoma, Non-Small-Cell Lung (metabolism, pathology)
  • Carcinoma, Squamous Cell (metabolism)
  • ELAV Proteins
  • ELAV-Like Protein 1
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Lung Neoplasms (metabolism, pathology)
  • Lymphatic Metastasis
  • Male
  • Microscopy, Confocal
  • Middle Aged
  • RNA-Binding Proteins (biosynthesis, chemistry)
  • Vascular Endothelial Growth Factor C (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: